Retension and Lilly-backed TRex Bio both set out plans to join biotech IPO stampede

Eli Lilly-backed TRex Bio and hypertension-focused Retension Pharmaceuticals are the latest biotechs to set out plans to go public this year.

source

Reporting by Fierce Biotech.

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

Fierce Biotech5h ago1 min read

Eli Lilly-backed TRex Bio and hypertension-focused Retension Pharmaceuticals are the latest biotechs to set out plans to go public this year.

source

Reporting by Fierce Biotech.

5-min edit window · permanent after that

no comments yet — first sniff?